Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herceptin + XELOX for HER2+ Advanced Gastric Cancer
NCT01364493Phase 2Completed
- Sponsor
- Peking University
- Start
- May 2011
- Primary completion
- Aug 2012
- Countries
- 1
01
Overview
Phase 2, open-label trial of trastuzumab in gastric cancer (GC), sponsored by Peking University. Started May 2011; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01364493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364493.